Intuitive(US:ISRG) The Motley Foolยท2025-10-07 07:26Core Viewpoint - Intuitive Surgical is positioned to maintain its leadership in the surgical robotics market, despite recent stock declines and increasing competition [1][3]. Company Performance - Intuitive Surgical's stock has experienced a 26% decline from its peak earlier in the year, but it has delivered a remarkable 19,510% return since its IPO approximately 25 years ago [1][2]. - The company is currently in the process of rolling out its latest system, the da Vinci 5, which is expected to reach full deployment by the end of 2026 [3]. Product Development - The da Vinci 5 system features a new force feedback capability that enhances the surgical experience by allowing surgeons to apply less force, potentially resulting in reduced tissue damage and quicker recoveries [4]. - In the second quarter, 180 new da Vinci 5 systems were successfully placed, indicating a strong start for the product launch [5]. Market Competition - Intuitive Surgical faces competition from several large international companies, including Medtronic, Stryker, and Johnson & Johnson, which also offer robot-assisted surgical systems [2][3]. - The increasing number of competitors introduces uncertainty regarding the company's future performance, despite the potential success of the da Vinci 5 system [3].